These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 11702813)
1. Hypercoagulability: clinical assessment and treatment. Abramson N; Abramson S South Med J; 2001 Oct; 94(10):1013-20. PubMed ID: 11702813 [TBL] [Abstract][Full Text] [Related]
2. Thrombophilia and hypercoagulability. Hassouna HI Med Princ Pract; 2009; 18(6):429-40. PubMed ID: 19797918 [TBL] [Abstract][Full Text] [Related]
3. Management options for thrombophilias. Gallus AS Semin Thromb Hemost; 2005 Feb; 31(1):118-26. PubMed ID: 15706484 [TBL] [Abstract][Full Text] [Related]
4. [Venous thromboembolic pathology. New acquired risk factors or new data on acquired risk factors]. Drouet L Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1318-26. PubMed ID: 11794976 [TBL] [Abstract][Full Text] [Related]
5. Etiology and assessment of hypercoagulability with lessons from heparin-induced thrombocytopenia. Sniecinski RM; Hursting MJ; Paidas MJ; Levy JH Anesth Analg; 2011 Jan; 112(1):46-58. PubMed ID: 21081779 [TBL] [Abstract][Full Text] [Related]
6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
8. [Antiphospholipid syndrome and venous thromboembolism: the role of congenital thrombophilia]. Poli D; Gensini GF Ann Ital Med Int; 2005; 20(4):218-23. PubMed ID: 16610253 [TBL] [Abstract][Full Text] [Related]
9. Should patients with venous thromboembolism be screened for thrombophilia? Dalen JE Am J Med; 2008 Jun; 121(6):458-63. PubMed ID: 18501222 [TBL] [Abstract][Full Text] [Related]
10. Screening for inherited thrombophilia: indications and therapeutic implications. De Stefano V; Rossi E; Paciaroni K; Leone G Haematologica; 2002 Oct; 87(10):1095-108. PubMed ID: 12368166 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic issues in thrombophilia: a laboratory scientist's view. Favaloro EJ Semin Thromb Hemost; 2005 Feb; 31(1):11-6. PubMed ID: 15706470 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of thrombotic children with malignancy. Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962 [TBL] [Abstract][Full Text] [Related]
14. Venous thrombosis at unusual sites and the role of thrombophilia. Lussana F; Dentali F; Ageno W; Kamphuisen PW Semin Thromb Hemost; 2007 Sep; 33(6):582-7. PubMed ID: 17768690 [TBL] [Abstract][Full Text] [Related]
15. A retrospective study of the factors associated with hypercoagulability in the pediatric patients at a tertiary care children's hospital. Slamon N; Krueger LJ; Edelson M; Glutting JJ; Rittenhouse D Pediatr Crit Care Med; 2008 Sep; 9(5):511-6. PubMed ID: 18679139 [TBL] [Abstract][Full Text] [Related]
16. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy. James AH; Brancazio LR; Ortel TL Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990 [TBL] [Abstract][Full Text] [Related]
17. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation. Adams M Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304 [TBL] [Abstract][Full Text] [Related]